Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-02-08 to 2023-02-09
Current total value of award: $3875.53
Description: 4559874075!QUILLIVANT XR ORAL SUSP 150ML 5MG/ML